Emerging resistance pathways in lung cancer: what has ROS-1 taught us? (2018)

First Author: Alrifai D
Attributed to:  MSCTRAIL for lung cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21037/tlcr.2017.11.13

PubMed Identifier: 29531896

Publication URI: http://europepmc.org/abstract/MED/29531896

Type: Journal Article/Review

Volume: 7

Parent Publication: Translational lung cancer research

Issue: Suppl 1

ISSN: 2218-6751